Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: mattstat who wrote (10538)	6/19/2018 9:45:04 PM
From: BoredMember	Read Replies (1) \| Respond to of 12871

1) Dr. Anil Diwan was able to swap out over $5M in stock for cash by building the lab and then selling it back to Nanoviricides. 2) Dr. Anil Diwan has personally made well over $20M (maybe as much as ($40M+) in cash, stock, bonus, salary (between himself, his wife and his family) and the thirty percent mark up on all direct and indirect expenses incueyreed by Theracour. 3) Dr. Eugene Seymour well over $10M when you include all family shares, salary, bonus, stock, and reimbursement of all expenses. As I said before, which you apparently do not understand, I think your definition of success is very different than theirs. Is that simple enough? Maybe you parsed my post where I said: Nanoviricides IS performing as intended!Since inception, Dr. Eugene Seymour's and Dr. Anil Diwan's plans have been way more successful than they imagined.